Atlas Trials

Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma

Clinical trial NCT03868943 · TERMINATED

Trial details

NCT number
NCT03868943
Sponsor
Wake Forest University Health Sciences
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
GliomaGlioblastoma
Start date
2021-01-27
Primary completion
2021-11-22
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.